iBionext

iBionext is a Paris-based venture studio specializing in the creation, development, and financing of innovative startups in the healthcare and deep tech sectors. Established in 2016, it focuses on transforming disruptive technologies into market-leading companies. The firm operates through a three-stage investment strategy: Spot, Boost, and Grow. In the Spot phase, iBionext identifies promising healthtech innovations from its extensive scientific and academic network, collaborating with founders to prepare them for high-potential startups. During the Boost phase, it creates and funds selected startups, ensuring they have the necessary financial resources and operational support to achieve their objectives. In the Grow phase, iBionext supports the growth of these companies, leveraging its network to help them become leaders in their respective fields and assisting in their growth and exit strategies. By the end of 2023, the first iBionext Growth Fund had co-founded and built six high-potential companies in the biotech, medtech, digital health, and deep tech sectors, collectively raising over €200 million and creating more than 200 highly qualified jobs. The firm's team comprises experienced entrepreneurs and investors with expertise in company creation, development, and financing of disruptive innovations in healthcare. They work closely with portfolio companies to maximize value creation and returns for investors. iBionext's unique ecosystem, located in the heart of Paris, provides ongoing operational support, enabling managers to focus on their company's success. This approach has led to the creation of multiple companies that have raised significant funds and created numerous skilled jobs, demonstrating iBionext's commitment to fostering innovation and growth in the healthtech sector.